Swine influenza A vaccines, pandemic (H1N1) 2009 virus, and cross-reactivity

Emerging Infectious Diseases

Volumn 16, Issue 6, 2010, Pages 1029-1030

  Dürrwald, Ralf ^a   Krumbholz, Andi ^b   Baumgarte, Sigrid ^c   Schlegel, Michael ^a   Vahlenkamp, Thomas W ^d   Selbitz, Hans Joachim ^a   Wutzler, Peter ^b   Zell, Roland ^b  

^a IDT Biologika GmbH   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c Institutes für Hygiene und Umwelt   (Germany)

^d FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOMER; MINERAL OIL; SWINE INFLUENZA VACCINE; TRIPLE VACCINE;

ANTIBODY TITER; BLOOD SAMPLING; CROSS REACTION; DRUG EFFICACY; DRUG SAFETY; HEMAGGLUTINATION INHIBITION; IMMUNOFLUORESCENCE TEST; INCUBATION TIME; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; LETTER; NONHUMAN; PANDEMIC; SERODIAGNOSIS; SWINE; SWINE INFLUENZA VIRUS; VIRUS STRAIN; VIRUS TRANSMISSION;

ACRYLIC RESINS; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H1N2 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; MINERAL OIL; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE INFECTIONS; SWINE; TREATMENT OUTCOME;

EID: 77952686477     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1606.100138     Document Type: Letter

References (8)

1. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009;325:197-201. DOI: 10.1126/science.1176225
2. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature. 2009;459:1122-5. DOI: 10.1038/nature08182
3. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, et al. In vitro and in vivo characterization of new swineorigin H1N1 influenza viruses. Nature. 2009;460:1021-5.
4. Influenza pandemic (H1N1), animal. Latest information on influenza A (H1N1) [cited 2010 Jan 31]. http://www.promedmail.org
5. Hofshagen M, Gjerset B, Er C, Tarpai A, Brun E, Dannevig B, et al. Pandemic influenza A(H1N1)v: Human to pig transmission in Norway? Euro Surveill. 2009; 14:pii=19406.
6. Brookes SM, Irvine RM, Nunez A, Clifford D, Essen S, Brown IH, et al. Influenza A (H1N1) infection in pigs. Vet Rec. 2009;164:760-1.
7. Kyriakis CS, Olsen CW, Carman S, Brown IH, Brookes SM, Van Doorsselaere J, et al. Serologic cross-reactivity with pandemic (H1N1) 2009 virus in pigs, Europe. Emerg Infect Dis. 2010;16:96-9.
8. Lange E, Kalthoff D, Blohm U, Teifke JP, Breithaupt A, Maresch C, et al. Pathogenesis and transmission of the novel swine-origin influenza virus A/H1N1 after experimental infection of pigs. J Gen Virol. 2009;90:2119-23. DOI: 10.1099/vir.0.014480-0